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Gravity is an important factor during the evolution and development of life on Earth. During spaceflight, considerable stress on the cardiovascular system results from the redistribution of body fluids toward the head (White and Blomqvist 1998) .
Long-term microgravity exposure results in decreases in cardiac preload and function, as evidenced by echocardiographs of astronauts showing decreases in left ventricular end diastolic volume and ventricular stroke volume (Herault et al. 2000; YuZhang and Jin 2001) In addition, rats flown in space for 14 days showed a decreased average cross-sectional area of the myocytes in the left ventricular muscle, indicating myocardial atrophy (GoldsteinEdwards and Schroeter 1992) . These observations suggest that prolonged exposure to microgravity may continue to affect cardiac tissue regenerative growth and repair, resulting in more widespread degenerative effects.
Alternatively, myocardium may adapt to microgravity and reach a new homeostatic level sufficient for health maintenance. These adaptive changes within the cardiac muscle might affect crew health and safety, especially back on Earth. Similar changes were found in the hearts of chronic bedridden and paraplegic patients (Kashihara et al. 1994; Kessler et al. 1986 ). The prevalence of coronary artery disease in individuals with paraplegia is much higher than that in the general population (Thom et al. 2006) .
However, whether the simulated microgravity increases susceptibility to MIR injury is uncertain.
MIR injury, accompanied by contractile dysfunction and cellular damage, is still one of the primary causes of death (Lim et al. 2013) . The ischemic heart exhibits decreased oxidative metabolism of both FFAs and glucose, which increases the D r a f t AMP/ATP ratio. As a result, AMPK is rapidly activated as part of an innate cardiac survival mechanism (Dyck and Lopaschuk 2006) . Once activated, AMPK stimulates glucose uptake and glycolysis during ischemia and increases autophagic activity during ischemia-reperfusion (Matsui et al. 2007) . Moreover, the activation of AMPK by low-flow ischemia limits apoptosis and protects against ischemic injury (Russell et al. 2004) . A recent study by Gundewar et al. revealed that the activation of AMPK by metformin significantly increased survival and improved ventricular function (Gundewar et al. 2009 ). Conversely, genetic mouse models with impaired cardiac AMPK activation sustain increased injury during ischemia-reperfusion (Calvert et al. 2008; Russell et al. 2004; Wang et al. 2009 ). In addition, AMPK inactivation has been linked to diabetes, as demonstrated by Viollet et al. (Viollet et al. 2003) . Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury (Paiva et al. 2011) . Therefore, we hypothesized that AMPK deficiency would increase the susceptibility of the heart to IR injury in rats subjected to simulated microgravity.
In the present study, we used two models-a rat model with 4 weeks of tail suspension to simulate microgravity and a Langendorff-perfused heart model with 300 beats/min pacing-and one AMPK activator of A-769662 to investigate whether simulated microgravity increases MIR injury via a deficiency of AMPK.
Methods

Ethical Approval
All animal studies were carried out in accordance with the Guide for the Care D r a f t
and Use of Laboratory Animals of the National Institutes of Health. All experiments involving rats were reviewed and approved by the Ethics Committee for animal care and use of Fourth Military Medical University, P.R. China.
Hindlimb unweighting rat model
The technique of hindlimb unweighting (Morey-Holton and Globus 2002), with modification, from our laboratory has been described in detail previously (Sun et al. 2004; Zhang et al. 2003) . Male SD rats were attached with tape to a plastic bar with a swivel mounted at the top of the cage allowing free 360° rotation. The rats were maintained in an approximately -30° head-down tilt position with their hindlimbs unweighted. The rats were weighed daily throughout the experiment. Furthermore the rats were closely monitored several times daily for grooming behavior, eating and drinking, moving freely, urination and defecation and inspection of the tail. Typically, the ends of the tails in tail-suspension rats are only slightly engorged and appear pink.
If the end of the tail appears swollen or has a blue tint, corrective actions need to be taken immediately to ensure proper circulation in the tail. The controls were housed in identical Plexiglas cages, except that the tail suspension device was removed. All animals received standard lab chow and water ad libitum and were caged individually in a room maintained at 23°C on a 12:12-h light-dark cycle.
Preparation of isolated hearts
The isolated crystalloid-perfused rat heart has previously been described (Barbato et al. 2005) . Rats were heparinized (500 U i.p.) and anesthetized with sodium pentobarbital (40 mg/kg i.p. into the left ventricle through the left atrial appendage and was inflated to achieve an end diastolic pressure of 8 to 10 mmHg. Electrodes placed on the aortic cannula and the apex of the ventricle was connected to a square wave stimulator (Aurora Scientific
Inc., Aurora, Canada; 5 ms pulse duration, 20 V pulse amplitude). The hearts were paced at 300 beats/min.
A surgical needle was passed under the origin of the LAD, and the ends of the suture were passed through a pipette tip to form a snare. Regional ischemia was induced by tightening the snare, and reperfusion was performed by releasing the ends D r a f t
Eighty male SD rats were randomly assigned to eight experimental groups (n=10 rats/group): control hearts (CON), 4 weeks of tail suspension hearts (SUS), control hearts subjected to 30 min ischemia (CON + Vehicle + 30 IR), tail suspension hearts subjected to 30 min ischemia (SUS + Vehicle + 30 IR), control hearts subjected to 60 min ischemia (CON + Vehicle + 60 IR), tail suspension hearts subjected to 60 min ischemia (SUS + Vehicle + 60 IR), control hearts treated with A-769662 (20 µmol/L) added to the perfusate 30 min prior to ischemia (CON + A-769662 + 60 IR) and tail suspension hearts treated with A-769662 (20 µmol/L) added to the perfusate 30 min prior to ischemia (SUS + A-769662 + 60 IR). All Langendorff-perfused hearts were applied for the 120 min of reperfusion.
Measurements of infarct size
Hearts were arrested in diastole by briefly perfusing with cardioplegic solution (25 mM KCl, 5% dextrose in phosphate buffered saline) at the end of reperfusion. To distinguish between viable and infarcted tissue, hearts were perfused and incubated in 1% triphenyltetrazolium chloride (TTC, in phosphate buffer, pH 7.4) for 10 min at 37°C. Subsequently, the LAD was retied in the same place and the heart perfused with 1% Evans Blue (in dH 2 O, filtered) to distinguish between areas perfused and those not perfused during the LAD occlusion (area at risk, AAR 
LDH and CK release
The coronary effluent was collected immediately before reperfusion and at 1, 5, and 10 min of reperfusion to measure creatine kinase (CK) and lactate dehydrogenase (LDH) in all the groups. The activity of CK and LDH, as markers of myocardial injury, was measured in coronary effluent using Hughes' method (HUGHES 1962) and the 2-4 DNPH method (KING 1959) , respectively. Values were expressed in international units per liter (IU/L)
Western blotting
The expressions of P-AMPKα1/2 (Thr 172), AMPKα1/2, Bax and Bcl-2 were detected by Western blotting. Left ventricular myocardium and myocardium in the border zone after ischemia-reperfusion were homogenized in a buffer containing 50 mM potassium phosphate buffer (pH 7.0), 0.5 mM DTT, 1 mM EDTA, 0.3 mM PMSF, and phosphatase inhibitor cocktail (1 : 100, Sigma-Aldrich). Samples were subjected to SDS-PAGE in polyacrylamide gels at either 10% or 12% depending on their protein molecular weight. Quantification analysis of blots was performed with the Scion Image software.
Immunofluorescent staining
Hearts were removed after ischemia-reperfusion, fixed in 4% paraformaldehyde, embedded into OCT compound, quickly frozen at -80°C, and then processed for cryosectioning (5 µm thickness). Ten sections were prepared at 10 different transversal levels at the site of tissue necrosis, equally distributed from base to apex.
After the cryosections were fixed with acetone at 4°C for 30 min, the sections were stained with anti-Cx43 anti-rabbit IgG second antibody. Hoechst 33342 (5 µg/mL, Molecular Probe) was used to label the nuclei. The sections were examined using a laser-scanning confocal microscope equipped with the FV10-ASW system (Olympus FV1000). The images were analyzed using Image-Pro Plus 5.0 software (Media Cybernetics Inc., Rockville, Md., USA)
TUNEL staining and analyses
After frozen sections were fixed, the apoptotic nuclei were labeled using terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay according to the manufacturer's instructions. In this procedure, apoptotic nuclei were stained green. The nuclei of cells were counterstained with Hoechst 33342 (5 µg/mL).
The labeled cells were counted under a confocal microscope (Olympus FV1000). The percentage of apoptotic cells was calculated as the ratio of TUNEL-positive cells to
Hoechst 33342-stained total cells counted in ten different random fields.
Statistical analysis
Values are expressed as means ± SEM (except for body weight data, which are means ± SD). Two-way ANOVA with repeated measures was used to determine the overall differences among different groups and different recording sessions of the same group. The 0.05 level of probability was chosen as significant for all analyses.
D r a f t
The data are summarized in Table 1 . There were no significant differences in the final body weight and heart weight between tail suspension rats and control rats. The wet weight of the soleus of SUS rats was 64.5 ± 0.4% less than that of the CON rats (P<0.01), indicating that the hindlimb unweighting rodent model was successful (Morey-Holton and Globus 2002).
Changes in cardiac hemodynamic function during the ischemia-reperfusion period
Cardiac output values exhibited a decrease of more than 30% after occlusion of the LAD. Subsequently, the cardiac output values during the reperfusion (120 min) period significantly rebounded but remained lower than the values recorded before LAD occlusion ( Fig. 1) . Furthermore, during the 30 min of ischemia and 120 min of reperfusion periods, the values of cardiac output did not significantly differ between suspension and control groups (Fig. 1A) . However, the cardiac output was significantly decreased in suspension rats relative to controls when the rats were subjected to 60 min of ischemia followed by 120 min of reperfusion, pretreatment with A-769662 (20 µmol/L) for 30 min increased cardiac output by an average of 12.9 ± 0.3% in control groups and by an average of 19.1 ± 0.4% in suspension groups (Fig.   1B ). Changes in LVESP were similar to changes in cardiac output. LVESP, which averaged 93 ± 3.6 mmHg before LAD occlusion, significantly decreased to 45 ± 1.5 mmHg and 53 ± 1.8 mmHg at 30 and 60 min of occlusion, respectively. Subsequently,
the LVESP values increased to 71 ± 1.9 mmHg and 66 ± 1.6 mmHg in the same hearts after 120 min of reperfusion, respectively ( Fig. 2A and B ). During the 30 min D r a f t of ischemia and 120 min of reperfusion periods, the values of LVESP did not significantly differ between suspension and control groups ( Fig. 2A ), but it was significantly reduced in suspension rats relative to controls when the rats were subjected to 60 min of ischemia followed by 120 min of reperfusion. Pretreatment with A-769662 significantly increased LVESP values to an average of 139 ±4.9 mmHg in control groups and 161 ± 5.6 mmHg in suspension groups (Fig. 2B ). The LVEDP averaged 1.9 ± 0.5 mmHg before LAD occlusion and significantly increased to 4.6 ± 0.9 mmHg and 17.5 ± 2.1 mmHg at 30 and 60 min of occlusion, respectively.
Subsequently, LVEDP values increased to 6.7 ± 0.9 mmHg and 12.4 ± 1.1 mmHg in the same hearts after 120 min of reperfusion ( Fig. 2C and D) . During the 30 min of ischemia and 120 min of reperfusion periods, the values of LVEDP did not significantly differ between suspension and control groups (Fig. 2C) . However, the LVEDP was significantly increased in suspension rats relative to controls when the rats were subjected to 60 min of ischemia followed by 120 min of reperfusion, and pretreatment with A-769662 significantly decreased LVEDP values to an average of 0.2 ± 0.2 mmHg in control groups and 0.7 ± 0.3 mmHg in suspension groups (Fig.   2D ).
Biochemical analysis
The activities of CK and LDH in coronary effluent were used to monitor the damage of myocardium. During the early reperfusion period, large increases in CK and LDH were observed in coronary effluent. The peak release of CK and LDH was noted after 5 min of reperfusion, and these values declined with the ongoing D r a f t reperfusion (Fig. 3) . After 30 min ischemia, the measurement of CK and LDH revealed no significant differences between suspension and control rats ( Fig. 3A and   C ), but these values were significantly increased in suspension rats relative to controls when the rats were subjected to 60 min of ischemia, and the A-769662-treated group showed a significant decrease in CK and LDH activity compared to untreated group ( Fig. 3B and D) .
Myocardial infarct size
As shown in Fig. 4 , the myocardial infarct size was greater in the suspension group than that in control group, but the difference did not reach statistical significance when the rats were subjected to 30 min of LAD occlusion followed by 120 min of reperfusion ( Fig. 4A and C) . However, when the duration of LAD occlusion was extended to 60 min followed by 120 min of reperfusion, a significantly greater infarct size was observed in the suspension group relative to the control group 
AMPK activity in the tail-suspension rat heart
AMPK is an evolutionarily conserved serine-threonine protein kinase which coordinates cellular metabolic stress responses (Hardie 2004) .AMPK is a heterotrimeric complex containing a catalytic α and regulatory β and γ subunits. The α subunit contains an N-terminal catalytic domain including the Thr-172 residue which is phosphorylated (P-AMPKα) leading to activation of the enzyme.
Previous extensive studies have shown AMPK activation protects ischemic D r a f t heart. (Calvert et al. 2008; Russell et al. 2004; Tian and Balschi 2006; Xing et al. 2003) So we evaluated the protein expression of P-AMPKα (Thr-172) and AMPKα by Western blot assay. The AMPKα protein expression of the left ventricular myocardium in rats subjected to 4 weeks of tail suspension revealed a significant suppression compared with controls (Fig. 7) . And after the ischemia (60 min)-reperfusion (120 min), the protein expression of AMPKα and P-AMPKα in the suspension group was less than that in the control group, but P-AMPKα decreased more obviously, so the ratio of P-AMPKα/AMPKα in the suspension group was lower compared with the control group ( Fig. 8 ) (P<0.05). Therefore, tail suspension remarkably decreases AMPK activity in the ischemia (60 min)-reperfusion (120 min) rat myocardium. AMPK expression was the internal control, so pretreatment with A-769662 did not alter the expression levels of AMPKα, whereas it greatly increased the levels of P-AMPKα. Therefore, P-AMPKα/AMPKα ratio in A-769662-treated groups was higher than it was in the untreated groups ( Figure 2) . So, the present study suggest that SUS hearts during long-term ischemia injury do not increase autophagy and oncosis.
D r a f t
Apoptosis is the opposite of oncosis: apoptosis manifests itself by cell shrinkage followed by breakup. And in our study, TUNEL staining demonstrated that the percentage of TUNEL-positive cardiomyocytes was significantly higher in the suspension group than that in the control group (Fig. 6 ) (P<0.01), and the A-769662-treated group showed a significant decrease in TUNEL-positive cardiomyocytes compared to the untreated group (Fig. 6 ) (P<0.01). In addition, using western blot analysis, we found that no significant difference was detected in the protein expression of Bcl-2 and Bax between suspension and control rats (Fig. 7) .
And after the ischemia (60 min)-reperfusion (120 min), the expression of Bax did not alter, whereas the expression of Bcl-2 was greatly reduced in the suspension group relative to the control group. The relative ratio of Bcl-2/Bax in the suspension group was less than that in the control group (Fig. 9 ) (P<0.01). Pretreatment with A-769662
did not alter the expression levels of Bax, whereas it greatly increased the levels of Bcl-2. Therefore, the Bcl-2/Bax ratio was significantly higher in A-769662-treated groups compared with in the untreated groups. (Fig. 9 ) (P<0.01)
Discussion
The gravitational field is an important determinant of cardiovascular function.
After a prolonged exposure to weightlessness, the cardiovascular system is significantly inhibited, including a reduction in circulating blood volume, reduced cardiac output, reduced red cell mass, cardiac atrophy, and dysrhythmias (Campbell 2002 ). These changes likely impair the ability of astronauts to withstand injury (Campbell 2002; Kirkpatrick et al. 2009 ). MIR injury is one of the primary causes of D r a f t death. Whether the simulated microgravity hearts are more sensitive to IR injury is uncertain. We used two models (a rat model subjected to 4 weeks of tail suspension to simulate microgravity and a Langendorff-perfused heart model with 300 beats/min pacing) to investigate whether simulated microgravity increases myocardial susceptibility to IR injury via a deficiency of AMPK. The following discussion focuses on the relevance of our findings.
Simulated microgravity increases myocardial susceptibility to IR injury
As a convenient model of simulated weightlessness on the ground, tail suspension rats have been widely used to investigate the effects of a microgravity environment on the cardiovascular system (Yu et al. 2001) . In the present study, using a Langendorff-perfused heart model with the application of different durations of ischemia, we demonstrated that the prolongation of ischemia but not reperfusion from 30 min to 60 min significantly increased infarct size in SUS compared to CON. The results showed that the severity of the post-ischemic injury of the SUS hearts depended more on the duration of ischemia than on that of reperfusion. Myocardial infarct size is a major determinant of prognosis in patients with ischemic heart disease (Alegria et al. 2007) . Larger infarct size is related to higher rates of onset of severe congestive heart failure after reperfusion therapy, as observed in diabetes patients (Marso et al. 2007) . These findings suggested the diabetic hearts are more sensitive to IR injury than hearts from non-diabetic subjects (Li et al. 2013; Marso et al. 2007) . In concordance with the diabetic hearts, simulated microgravity increases infarct size and renders the hearts more vulnerable to IR injury.
D r a f t
AMPK deficiency increases the susceptibility of rats subjected to simulated microgravity to MIR injury
The most interesting observation of the present study was that the AMPKα protein expression of the left ventricular myocardium was significantly suppressed after 4 weeks tail suspension. It has been demonstrated that reduced AMPKα expression in cardiomyocytes is harmful to the ischemic heart because of the reduction of glucose uptake and ATP homeostasis (Russell et al. 2004 ). Carvajal et al. (Carvajal et al. 2007) reported that AMPKα2 -/-mice exhibited an accelerated development of the ischemic contracture in global ischemia. An early rise in the ischemic contracture has been observed in other transgenic mice, such as the over-expression of dominant-negative α2 kinase mice (AMPKα2 DN) (Xing et al. 2003 ) and the α2 kinase dead (KD) mice (Russell et al. 2004) . Furthermore, studies from several laboratories suggested that AMPK activation by A-769662 protects the heart against ischemic injury (Ducommun et al. 2014; Kim et al. 2011) . Together with the results of the present study, rats pre-treated with A-769662 exhibited better recovery of left ventricular contractile function and reduced responsiveness to IR injury in SUS hearts. These observations indicate that simulated microgravity rats exhibit enhanced myocardial susceptibility to IR injury via AMPK deficiency
The major role of AMPK is to respond to alterations in the AMP/ATP ratios and control the energy homeostasis of the cell. In times of low energy supply, AMPK responds by either switching off energy-consuming pathways or by promoting energy-producing processes. In the heart, ischemia is a physiologically important D r a f t condition that results in diminished ATP supply (Kudo et al. 1996) . During myocardial ischemia, AMPK activation has been shown to promote the translocation of GLUT4 to the plasma membrane, thus stimulating glucose uptake (Geraghty et al. 2007; Shirwany and Zou 2014) . In addition, the activation of AMPK accelerates fatty acid oxidation rats upon reperfusion (Kudo et al. 1996) .
In the present study, we used a model of partial ischemia. Degradation products (mainly lactate, protons, and adenosine) are washed out of the cell, enabling the continuation of glycolytic ATP production. Consequently, mitochondrial substrate oxidation still occurs in response to a remnant oxygen supply. Indeed, a 30 min period of flow restriction down to 10% induced a moderate decrease in ATP, as previously reported (Cave et al. 2000) , and rapidly led to a new metabolic and contractile steady state. As previously observed in AMPKα2 KO mice, LVEDP increased at a greater rate and to a greater extent, resulting in a decreased time to the start and a greater extent of maximal ischemic contracture (Folmes et al. 2009 ). The ischemic contracture results mostly from increased energy demand and exacerbated ATP depletion (Xing et al. 2003) . In our study, the prolongation of ischemia from 30 min to 60 min significantly increased LVEDP in SUS compared to CON rats, implying a faster ATP depletion in SUS hearts after 30 min ischemia. Furthermore , significant reduction in the phosphorylation of AMPK was observed in SUS as compared to 
Apoptotic activity increases myocardial IR injury due to simulated weightlessness
Numerous studies have found that the inactivation of AMPK blunts fatty acid oxidation, reduces lactate production during reperfusion, and increases myocardial injury (Carvajal et al. 2007; Russell et al. 2004; Wang et al. 2009 ). These results were consistent with the contention that the metabolic effects of AMPK on glucose transport and glycolysis were beneficial during low-flow ischemia. It seems, however, that AMPK may activate additional pathways, which are cardioprotective during ischemia and reperfusion. As previously observed in AMPKα2 KO, AMPKα2 DN and KD mice, MIR-induced cardiomyocyte apoptosis was increased and infarct size was enlarged (Folmes et al. 2009 ). In our study, the increased IR injury colocalized with (Hochhauser et al. 2007) . By contrast, Bcl-2 has anti-apoptotic effects that can promote cell survival by blocking the release of the cytochrome C pathway via the stabilization of the mitochondria. Overexpression of Bcl-2 in cultured cardiac cells exposed to hypoxia not only reduces apoptosis but decreases cytochrome c release from the mitochondria (Kang et al. 2000) . Similarly, overexpression of Bcl-2 in transgenic animals reduces both infarct size and apoptosis following MIR (Scarabelli et al. 2006) . The present study showed that there was no significant difference in the protein expression of Bax between SUS and CON hearts after the ischemia (60 min)-reperfusion (120 min). Otherwise, the expression of Bcl-2 was greatly reduced in SUS relative to CON hearts. Consequently, the relative ratio of Bcl-2 to Bax (Bcl-2/Bax) in SUS was lower than that in CON hearts after these hearts D r a f t were subjected to 60 min of ischemia followed by 120 min of reperfusion. Bcl-2/Bax reflects mitochondrial-dependent apoptosis under stress conditions. Therefore, SUS rats exhibit increased MIR injury via the activation of the apoptosis pathway. In addition, A-769662 decreased MIR injury via the activation of AMPK (Kim et al.
2011), and AMPK activation increase increased the levels of Bcl-2 and Bcl-2/Bax in cardiomyocyte (Yeh et al. 2010) . Indeed, the present study found that A-769662 treatment greatly increased the levels of Bcl-2 and Bcl-2/Bax compared to the untreated groups. These results suggest the rats subjected to simulated microgravity increase MIR injury via a deficiency of AMPK, which increases the mitochondrial-dependent apoptosis pathway.
Limitations
There are several limitations to the present study. First, to further verify our findings, animal in vivo models should be used. Second, this work lacks a description of a detailed molecular mechanism. Further study should focus on a cell model system with biochemistry and molecular biological methods. Finally, although rats and humans share a very high degree of genomic similarity, our findings generated from rats should be cautiously extrapolated to humans.
Conclusions
To our knowledge, this is the first systematic study to investigate MIR injury in rats subjected to simulated microgravity. Our present evidence indicates that the decreased expression of AMPKα might cause the increased infarct size in SUS rats during long-term ischemia injury. This effect may be attributed to several causes, D r a f t including reduced energy compensatory ability, mitochondrial damage and increased apoptosis in border zones of the heart. These findings may suggest that hearts subjected to simulated microgravity are more sensitive to IR injury. tail suspension ischemic group; £P<0.05 vs. control ischemic group treated with A-769662.
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